Long COVID Symptoms in SARS-CoV-2-positive Children in China

NCT ID: NCT05729217

Last Updated: 2023-03-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

5000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-02-01

Study Completion Date

2024-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to learn about in children aged 6-18 years, after the acute phase of SARS-CoV-2 infection, the COVID symptoms or Long COVID symptoms to impact their daily activities. We aimed to investigate the prevalence of long-lasting symptoms, the duration and intensity of symptoms, quality of life, number of sick days or absences from school, and psychological and social outcomes. The participants will be asked to fill in Long COVID symptom burden questionnaires who had been infected with SARS-CoV-2 as self-reported PRC test or antigen test positive.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of this observational study is to learn about in children aged 6-18 years, after the acute phase of SARS-CoV-2 infection, the COVID symptoms or Long COVID symptoms to impact their daily activities. We aimed to investigate the prevalence of long-lasting symptoms, the duration and intensity of symptoms, quality of life, number of sick days or absences from school, and psychological and social outcomes.

The participants will be asked to fill in SBQ-Long COVID symptom burden survey questionnaires who had been infected with SARS-CoV-2 as self-reported PRC test or antigen test positive.

The survey questionnaires will be filled every two weeks after the participants have been tested SARS-CoV-2 positive.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Symptoms and Signs

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1 aged 7-12 years

Group 1 will mainly be primary school students from grade 1 to 6.

SBQ-LC survey

Intervention Type OTHER

Symptom burden questionnaires of Long COVID

Group 2 aged 13-15 years

Group 2 will mainly be middle school students from grade 13 to 15.

SBQ-LC survey

Intervention Type OTHER

Symptom burden questionnaires of Long COVID

Group 2 aged 16-18 years

Group 3 will mainly be high school students from grade 16 to 18.

SBQ-LC survey

Intervention Type OTHER

Symptom burden questionnaires of Long COVID

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SBQ-LC survey

Symptom burden questionnaires of Long COVID

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

infected with SARS-CoV-2 as self-reported PRC test or antigen test positive or have symptoms, but without Covid-19 test.

Exclusion Criteria

aged below 6 years or above 18 years
Minimum Eligible Age

7 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Capital Institute of Pediatrics, China

OTHER

Sponsor Role collaborator

Tim Shi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tim Shi

Director

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jun Ting Liu, MD

Role: STUDY_DIRECTOR

Capital Institute of Pediatrics, China

Tim Shi, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

GlobalMD Organization

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Capital Institute of Pediatrics

Beijing, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Children COVID Symptoms

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Fast Food Feeding in Youth
NCT00121706 COMPLETED NA